Who will win the race for the first CFTR gene replacement therapy? - PubMed
5 hours ago
- #medical research
- #pharmaceutical competition
- #CFTR gene therapy
- The article discusses the competition to develop the first CFTR gene replacement therapy.
- Y.M. has filed a provisional patent for RNA delivery using lipid nanoparticles and has collaborated with ReCode Therapeutics.
- M.A.M. has received grants from various organizations including the German Research Foundation and Vertex Pharmaceuticals.
- M.A.M. has consultancy fees, honoraria, and travel reimbursements from multiple pharmaceutical companies.
- M.A.M. is an unpaid fellow of the European Respiratory Society.